Skip to main content

In vitro activity of chloroquine, quinine, mefloquine and halofantrine against Gabonese isolates of Plasmodium falciparum

Buy Article:

$43.00 plus tax (Refund Policy)

Summary objectives 

To determine the in vitro activity of antimalarial drugs against isolates of Plasmodium falciparum in Gabon. methods 

Plasmodium falciparum isolates were collected from symptomatic infections in the hospitals of Bakoumba and Franceville, south-east Gabon and in 2000. In vitro activity of chloroquine, quinine, mefloquine, halofantrine was measured by the isotopic microtest. results 

A total of 60 and 62 isolates gave interpretable data in Franceville and Bakoumba, respectively. In Franceville, 50.0% (mean IC50 = 111.7 nm), 0% (mean IC50 = 156.7 nm), and 21.2% (mean IC50 = 12.4 nm) of isolates, respectively, showed in vitro resistance to chloroquine, quinine and mefloquine. In Bakoumba, we saw resistance to chloroquine, quinine, mefloquine and halofantrine in 95.0% (mean IC50 = 325.8 nm), 10.2% (mean IC50 = 385.5 nm), 47.5% (mean IC50 = 24.5 nm) and 18.2% (mean IC50 = 1.9 nm) of isolates, respectively. Activities of chloroquine and mefloquine, chloroquine and quinine, and mefloquine and quinine were positively correlated. conclusions 

Antimalarial drug resistance is high in this area of Gabon. The extent of resistance is disparate, as all tested drugs were less efficacious in Bakoumba than in Franceville.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Keywords: Gabon; Plasmodium falciparum; chloroquine; halofantrine; in vitro test; mefloquine; quinine

Document Type: Research Article

Affiliations: 1: Centre International de Recherches Médicales de Franceville, Gabon, Central Africa 2: Université des Sciences et Techniques de Masuku (USTM), Franceville, Gabon, Central Africa 3: Bakoumba Hospital, Bakoumba, Gabon, Central Africa

Publication date: 2003-01-01

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more